--- title: "EU AI Act for Hospitals & Medtech Germany: Compliance 2026" description: "Medical AI faces the EU AI Act's strictest high-risk rules. Compliance guide for German hospitals, clinics, and medtech firms — August 2026." image: "https://compound.law/assets/images/og-image-en.webp" source: "https://compound.law/en-DE/ai-act/healthcare/" language: "en" --- ![AI in Healthcare](https://compound.law/assets/images/ai-act/ai_act_2.webp) ai-act # EU AI Act for Hospitals & Medtech Germany: Compliance 2026 29 January 2026 Healthcare AI can save lives. It can also cause serious harm if it fails. The EU understood this—medical AI faces some of the most comprehensive regulation under the AI Act, layered on top of existing medical device requirements. Our [EU AI Act compliance overview](https://compound.law/en-DE/ai-act/) explains how the regulation’s risk tiers apply, and healthcare sits firmly in the highest tier. For German healthcare providers and medtech companies, compliance is complex but navigable. ## Medical Devices Are High-Risk AI that qualifies as a medical device under the MDR is automatically high-risk under the AI Act. Diagnostic AI, clinical decision support, treatment planning systems, patient monitoring with clinical implications—all high-risk. Our [AI medical diagnosis compliance guide](https://compound.law/en-DE/compliance/ai-medical-diagnosis/) details the documentation and oversight obligations for diagnostic systems specifically. The good news: MDR compliance counts. If you’ve done conformity assessment under the Medical Device Regulation, you don’t need separate AI Act conformity assessment. But you still need to meet the substantive AI Act requirements, and the notified body process must address AI-specific risks. ## Administrative AI Is Different Not all healthcare AI touches patients. Scheduling systems, resource allocation, billing optimization, administrative automation—these support operations without making clinical decisions. They’re generally lower risk, though worker-affecting systems need transparency. The distinction is clinical vs. administrative. AI that affects patient care is high-risk. AI that affects hospital operations usually isn’t. ## Research and Development AI used purely for medical research, before any clinical application, has more flexibility. But the moment AI moves toward patient care—even in clinical trials—medical device and AI Act requirements engage. Research teams accelerating with AI should consult our [AI drug discovery compliance](https://compound.law/en-DE/compliance/ai-drug-discovery/) guide at the outset, before clinical transition triggers full obligations. ## What This Means Practically Healthcare organizations need to classify AI by function. Clinical AI needs integrated MDR and AI Act compliance. Administrative AI needs basic documentation and worker transparency—our [AI employee monitoring compliance](https://compound.law/en-DE/compliance/ai-employee-monitoring/) guide is relevant for HR and workforce management tools. The BfArM and medical device notified bodies are building AI Act expertise. For infrastructure decisions, [Azure OpenAI](https://compound.law/en-DE/tools/azure-openai/) and [AWS Bedrock](https://compound.law/en-DE/tools/aws-bedrock/) both publish healthcare-specific compliance documentation worth reviewing. ## How Compound Law Helps - AI system classification for healthcare - MDR and AI Act integration - Clinical AI compliance frameworks - Administrative AI documentation - Notified body coordination ## Frequently Asked Questions **Does MDR compliance satisfy AI Act?** Partly. MDR conformity assessment is recognized under Article 28 EU AI Act, but you still need to meet the substantive AI Act requirements for high-risk systems — including technical documentation under Articles 11–17, human oversight, and post-market monitoring. **Is scheduling AI high-risk?** Generally no. Administrative tools that don’t affect clinical decisions are lower risk. **What about AI in clinical trials?** Research AI has flexibility, but clinical application triggers full medical device and AI Act requirements. **Do I need legal support for an AI diagnostic tool that falls under both the MDR and the EU AI Act?** Yes. AI diagnostic tools that qualify as medical devices under the EU Medical Device Regulation (MDR) and as high-risk AI under the EU AI Act must simultaneously comply with both regulatory frameworks — and the intersection creates specific legal and technical challenges. The MDR requires CE marking via a notified body; that conformity assessment process is recognised under Article 28 EU AI Act. However, you still need to meet the substantive AI Act requirements separately: technical documentation, risk management, quality management, human oversight, and post-market monitoring. Compound Law advises MedTech companies and diagnostic AI developers on navigating the MDR–AI Act intersection, including dual-framework documentation strategies and notified body coordination. Our [AI medical diagnosis compliance guide](https://compound.law/en-DE/compliance/ai-medical-diagnosis/) details the specific obligations, and our [pharmaceutical AI Act page](https://compound.law/en-DE/ai-act/pharmaceuticals/) covers related GxP and clinical trial compliance situations. **How do the EU AI Act and the EU MDR interact for AI-powered medical devices?** The EU AI Act and the EU Medical Device Regulation (MDR) create overlapping but distinct compliance obligations for AI-powered medical devices in Germany. Under EU AI Act Article 28, AI systems already subject to MDR conformity assessment by a notified body do not need a separate AI Act conformity assessment — but they must still satisfy the substantive AI Act requirements for high-risk systems (Articles 9–17), including technical documentation, quality management, and post-market monitoring. Both frameworks align on transparency, documentation, and human oversight, but diverge on definitions and specific procedural requirements. MedTech companies should conduct a dual-framework gap analysis to identify where existing MDR compliance already satisfies AI Act obligations and where additional steps are needed. Compound Law advises healthcare and MedTech companies in Germany and the DACH region on integrated MDR and EU AI Act compliance strategies. ## Related Industry Guides [![EU AI Act timeline Germany for 2 August 2026 2 December 2027 and 2 August 2028](https://compound.law/assets/images/ai-act/ai_act_1.webp)](https://compound.law/en-DE/ai-act/august-2026-deadline/) [ai-act](https://compound.law/en-DE/ai-act/august-2026-deadline/) ### [EU AI Act Timeline Germany: 2 August 2026, 2027 and 2028](https://compound.law/en-DE/ai-act/august-2026-deadline/) [EU AI Act 2 August 2026 is not the only date. German businesses need the split timeline for transparency, stand-alone high-risk AI, and product AI.](https://compound.law/en-DE/ai-act/august-2026-deadline/) [![EU AI Act compliance requirements for financial services firms in Germany](https://compound.law/assets/images/ai-act/ai_act_4.webp)](https://compound.law/en-DE/ai-act/financial-services/) [ai-act](https://compound.law/en-DE/ai-act/financial-services/) ### [EU AI Act Financial Services Compliance Guide for Germany (updated 2026)](https://compound.law/en-DE/ai-act/financial-services/) [Which AI systems are high-risk in financial services, what August 2026 deadlines mean for German banks, and a practical compliance checklist.](https://compound.law/en-DE/ai-act/financial-services/) [![EU AI Act high-risk insurance compliance Germany underwriting claims](https://compound.law/assets/images/ai-act/ai_act_4.webp)](https://compound.law/en-DE/ai-act/insurance/) [ai-act](https://compound.law/en-DE/ai-act/insurance/) ### [EU AI Act for German Insurers: High-Risk AI Compliance Guide](https://compound.law/en-DE/ai-act/insurance/) [EU AI Act classifies insurance AI as high-risk. Underwriting, pricing, and claims obligations for German insurers — with a practical compliance checklist.](https://compound.law/en-DE/ai-act/insurance/) ## Frequently asked questions Partly. MDR conformity assessment is recognized under Article 28 EU AI Act, but you still need to meet the substantive AI Act requirements for high-risk systems — including technical documentation under Articles 11–17, human oversight, and post-market monitoring. Generally no. Administrative tools that don't affect clinical decisions are lower risk. Research AI has flexibility, but clinical application triggers full medical device and AI Act requirements. Yes. AI diagnostic tools that qualify as medical devices under the EU Medical Device Regulation (MDR) and as high-risk AI under the EU AI Act must simultaneously comply with both regulatory frameworks — and the intersection creates specific legal and technical challenges. The MDR requires CE marking via a notified body; that conformity assessment process is recognised under Article 28 EU AI Act. However, you still need to meet the substantive AI Act requirements separately: technical documentation, risk management, quality management, human oversight, and post-market monitoring. Compound Law advises MedTech companies and diagnostic AI developers on navigating the MDR–AI Act intersection, including dual-framework documentation strategies and notified body coordination. Our \[AI medical diagnosis compliance guide]\(/en-DE/compliance/ai-medical-diagnosis/) details the specific obligations, and our \[pharmaceutical AI Act page]\(/en-DE/ai-act/pharmaceuticals/) covers related GxP and clinical trial compliance situations. The EU AI Act and the EU Medical Device Regulation (MDR) create overlapping but distinct compliance obligations for AI-powered medical devices in Germany. Under EU AI Act Article 28, AI systems already subject to MDR conformity assessment by a notified body do not need a separate AI Act conformity assessment — but they must still satisfy the substantive AI Act requirements for high-risk systems (Articles 9–17), including technical documentation, quality management, and post-market monitoring. Both frameworks align on transparency, documentation, and human oversight, but diverge on definitions and specific procedural requirements. MedTech companies should conduct a dual-framework gap analysis to identify where existing MDR compliance already satisfies AI Act obligations and where additional steps are needed. Compound Law advises healthcare and MedTech companies in Germany and the DACH region on integrated MDR and EU AI Act compliance strategies. ## Structured data ```json [ { "@context": "https://schema.org", "@type": [ "Organization", "LegalService" ], "@id": "https://compound.law/#organization", "name": "Compound Law", "alternateName": "Compound Law — AI Law Firm", "url": "https://compound.law/", "logo": { "@type": "ImageObject", "url": "https://compound.law/press/logos/PNG/Compound_Law_Icon.png", "width": 1024, "height": 1024 }, "image": "https://compound.law/assets/images/og-image.webp", "description": "The AI-native law firm in Berlin for start-ups, mid-sized companies and corporates: commercial and contract law, data protection, the EU AI Act, trademarks, corporate law, and restructuring and insolvency. A lawyer reviews every result, billed at a flat fee.", "foundingDate": "2026", "founder": [ { "@type": "Person", "name": "Marko Bradic", "jobTitle": "CEO", "url": "https://compound.law/en-DE/tech-team/marko-bradic/", "sameAs": [ "https://www.linkedin.com/in/markobradic/" ], "knowsAbout": [ "Product strategy and development", "Scaling technology companies", "FinTech and financial services", "AI-powered product innovation", "Business operations and growth", "Digital transformation" ] }, { "@type": "Person", "name": "Mohit Tilwani", "jobTitle": "CTO", "url": "https://compound.law/en-DE/tech-team/mohit-tilwani/", "sameAs": [ "https://www.linkedin.com/in/mohit-tilwani/" ], "knowsAbout": [ "Engineering leadership and architecture", "Scaling high-traffic systems", "AI and machine learning infrastructure", "FinTech platform development", "Cloud infrastructure and DevOps", "Product engineering" ] }, { "@type": "Person", "name": "Julian Jantze", "jobTitle": "Rechtsanwalt", "url": "https://compound.law/en-DE/lawyers/julian-jantze/", "sameAs": [ "https://www.linkedin.com/in/julian-jantze-957b95158/" ], "knowsAbout": [ "Corporate law and corporate governance for technology companies", "Employment law and HR compliance", "EU AI Act compliance and AI governance", "Employee participation models (VSOP/ESOP)", "Regulatory compliance for tech companies", "Legal operations and Legal Tech implementation" ] } ], "employee": [ { "@type": "Person", "name": "Marko Bradic", "jobTitle": "CEO", "url": "https://compound.law/en-DE/tech-team/marko-bradic/", "sameAs": [ "https://www.linkedin.com/in/markobradic/" ], "knowsAbout": [ "Product strategy and development", "Scaling technology companies", "FinTech and financial services", "AI-powered product innovation", "Business operations and growth", "Digital transformation" ] }, { "@type": "Person", "name": "Mohit Tilwani", "jobTitle": "CTO", "url": "https://compound.law/en-DE/tech-team/mohit-tilwani/", "sameAs": [ "https://www.linkedin.com/in/mohit-tilwani/" ], "knowsAbout": [ "Engineering leadership and architecture", "Scaling high-traffic systems", "AI and machine learning infrastructure", "FinTech platform development", "Cloud infrastructure and DevOps", "Product engineering" ] }, { "@type": "Person", "name": "Julian Jantze", "jobTitle": "Rechtsanwalt", "url": "https://compound.law/en-DE/lawyers/julian-jantze/", "sameAs": [ "https://www.linkedin.com/in/julian-jantze-957b95158/" ], "knowsAbout": [ "Corporate law and corporate governance for technology companies", "Employment law and HR compliance", "EU AI Act compliance and AI governance", "Employee participation models (VSOP/ESOP)", "Regulatory compliance for tech companies", "Legal operations and Legal Tech implementation" ] }, { "@type": "Person", "name": "Marc Schuba", "jobTitle": "Founding Partner, Rechtsanwalt (German attorney)", "url": "https://compound.law/en-DE/lawyers/marc-schuba/", "sameAs": [ "https://www.linkedin.com/in/marcschuba/" ], "knowsAbout": [ "IP and IT law", "SaaS and IT contracts, IT outsourcing", "Software and open-source licensing", "Data protection law (GDPR)", "AI law and the EU AI Act" ] }, { "@type": "Person", "name": "Dr. Markus Dreißigacker", "jobTitle": "Rechtsanwalt", "url": "https://compound.law/en-DE/lawyers/markus-dreissigacker/", "sameAs": [ "https://www.linkedin.com/in/markusdreissigacker" ], "knowsAbout": [ "M&A (Due diligence, post-merger integration, IPO readiness)", "Corporate Law (Governance, board work, restructuring)", "Commercial Law (Customer contracts, supplier agreements, NDAs)", "IP (Trademark management, IP transfer agreements)", "Compliance & ESG (Global compliance programs, human rights, sustainability)", "Data Protection (GDPR strategy, DPO experience, privacy programs)" ] }, { "@type": "Person", "name": "Philipp Brandt", "jobTitle": "Partner, Rechtsanwalt (German attorney), Specialist Lawyer for Intellectual Property Law", "url": "https://compound.law/en-DE/lawyers/philipp-brandt/", "sameAs": [ "https://www.linkedin.com/in/philipp-brandt-81b446a/" ], "knowsAbout": [ "Restructuring and insolvency law (crisis advice for management, protective shield and insolvency plan proceedings, insolvency administration)", "Intellectual property (trademarks, unfair competition, copyright, trade secrets, licence agreements)", "Data protection law (data breaches, regulatory fine proceedings, access and damages claims)", "Distribution and commercial law (distribution agreements, acquisition and sale of industrial plants)" ] } ], "address": { "@type": "PostalAddress", "addressLocality": "Berlin", "addressCountry": "DE" }, "areaServed": [ "Germany", "Austria", "Switzerland", "European Union", "United Kingdom", "United States", "Singapore" ], "availableLanguage": [ "de", "en" ], "serviceType": [ "AI law firm", "AI-native legal services", "legal counsel for start-ups and growth companies", "legal counsel for mid-sized companies and corporates", "Commercial Law", "Corporate Law", "Employment Law", "Regulatory & Compliance", "Intellectual Property", "Insolvency & Restructuring" ], "hasOfferCatalog": { "@type": "OfferCatalog", "name": "Compound Law services", "itemListElement": [ { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Commercial Contracts", "description": "Battle-tested contracts for your sales process", "serviceType": [ "enterprise contracts", "MSA", "DPA", "sales contracts" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "International Employment", "description": "Compliant hiring across borders", "serviceType": [ "international employment", "hiring abroad", "employment contracts" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "VSOP/ESOP Setup", "description": "Employee participation that actually works", "serviceType": [ "VSOP", "ESOP", "employee stock options", "equity incentives" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Funding Round Support", "description": "Clean legal for your next raise", "serviceType": [ "funding round", "term sheet", "SHA", "due diligence", "cap table" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Corporate Housekeeping", "description": "Get your legal house in order", "serviceType": [ "corporate governance", "board resolutions", "shareholder register" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Data Protection & Privacy", "description": "GDPR compliance that doesn't slow you down", "serviceType": [ "GDPR", "data protection", "privacy", "DPA", "cookies", "data breach response", "GDPR fines", "Art. 82 GDPR" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "AI Act Compliance", "description": "Navigate EU AI regulation", "serviceType": [ "AI Act", "AI compliance", "AI governance", "EU AI regulation" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "IP & Competition", "description": "Protect and enforce what you've built", "serviceType": [ "IP protection", "intellectual property", "trademarks", "trademark enforcement", "warning letters", "preliminary injunctions", "unfair competition", "software licensing", "open source compliance" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Fractional General Counsel", "description": "In-house legal without the full-time cost", "serviceType": [ "fractional GC", "fractional general counsel", "outsourced legal", "legal retainer" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "FinTech Compliance", "description": "Navigate financial regulation", "serviceType": [ "fintech compliance", "BaFin", "banking regulation", "AML", "KYC" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Legal Retainer", "description": "Predictable legal support when you need it", "serviceType": [ "legal retainer", "legal subscription", "ongoing legal support" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "M&A Preparation", "description": "Get ready for acquisition interest", "serviceType": [ "M&A preparation", "acquisition", "due diligence", "exit" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "name": "Restructuring & Insolvency", "description": "From the first liquidity check to the restructuring itself", "serviceType": [ "restructuring", "insolvency", "StaRUG", "self-administration", "insolvency plan", "director liability" ], "areaServed": [ "Germany", "European Union", "United Kingdom", "United States", "Singapore" ] } } ] }, "contactPoint": { "@type": "ContactPoint", "contactType": "sales", "email": "contact@compound.law", "availableLanguage": [ "English", "German" ], "areaServed": [ "DE", "AT", "CH", "EU", "GB", "US", "SG" ] }, "email": "contact@compound.law", "sameAs": [ "https://www.linkedin.com/company/compoundlawfirm", "https://x.com/CompoundLawFirm" ], "knowsAbout": [ "Commercial Contracts", "enterprise contracts", "MSA", "DPA", "sales contracts", "International Employment", "international employment", "hiring abroad", "employment contracts", "VSOP/ESOP Setup", "VSOP", "ESOP", "employee stock options", "equity incentives", "Funding Round Support", "funding round", "term sheet", "SHA", "due diligence", "cap table", "Corporate Housekeeping", "corporate governance", "board resolutions", "shareholder register", "Data Protection & Privacy", "GDPR", "data protection", "privacy", "cookies", "data breach response", "GDPR fines", "Art. 82 GDPR", "AI Act Compliance", "AI Act", "AI compliance", "AI governance", "EU AI regulation", "IP & Competition", "IP protection", "intellectual property", "trademarks", "trademark enforcement", "warning letters", "preliminary injunctions", "unfair competition", "software licensing", "open source compliance", "Fractional General Counsel", "fractional GC", "fractional general counsel", "outsourced legal", "legal retainer", "FinTech Compliance", "fintech compliance", "BaFin", "banking regulation", "AML", "KYC", "Legal Retainer", "legal subscription", "ongoing legal support", "M&A Preparation", "M&A preparation", "acquisition", "exit", "Restructuring & Insolvency", "restructuring", "insolvency", "StaRUG", "self-administration", "insolvency plan", "director liability" ] }, { "@context": "https://schema.org", "@type": "Article", "headline": "EU AI Act for Hospitals & Medtech Germany: Compliance 2026", "description": "Medical AI faces the EU AI Act's strictest high-risk rules. Compliance guide for German hospitals, clinics, and medtech firms — August 2026.", "image": "https://compound.law/assets/images/ai-act/ai_act_2.webp", "datePublished": "2026-01-29T00:00:00.000Z", "dateModified": "2026-01-29T00:00:00.000Z", "author": { "@type": "Person", "name": "Dr. Markus Dreißigacker", "image": "https://compound.law/assets/images/team/markusdreissigacker.webp" }, "publisher": { "@type": "Organization", "@id": "https://compound.law/#organization", "name": "Compound Law" }, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://compound.law/en-DE/ai-act/healthcare/" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://compound.law/en-DE/" }, { "@type": "ListItem", "position": 2, "name": "AI Act by Industry", "item": "https://compound.law/en-DE/ai-act/" }, { "@type": "ListItem", "position": 3, "name": "EU AI Act for Hospitals & Medtech Germany: Compliance 2026", "item": "https://compound.law/en-DE/ai-act/healthcare/" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Does MDR compliance satisfy AI Act?", "acceptedAnswer": { "@type": "Answer", "text": "Partly. MDR conformity assessment is recognized under Article 28 EU AI Act, but you still need to meet the substantive AI Act requirements for high-risk systems — including technical documentation under Articles 11–17, human oversight, and post-market monitoring." } }, { "@type": "Question", "name": "Is scheduling AI high-risk?", "acceptedAnswer": { "@type": "Answer", "text": "Generally no. Administrative tools that don't affect clinical decisions are lower risk." } }, { "@type": "Question", "name": "What about AI in clinical trials?", "acceptedAnswer": { "@type": "Answer", "text": "Research AI has flexibility, but clinical application triggers full medical device and AI Act requirements." } }, { "@type": "Question", "name": "Do I need legal support for an AI diagnostic tool that falls under both the MDR and the EU AI Act?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. AI diagnostic tools that qualify as medical devices under the EU Medical Device Regulation (MDR) and as high-risk AI under the EU AI Act must simultaneously comply with both regulatory frameworks — and the intersection creates specific legal and technical challenges. The MDR requires CE marking via a notified body; that conformity assessment process is recognised under Article 28 EU AI Act. However, you still need to meet the substantive AI Act requirements separately: technical documentation, risk management, quality management, human oversight, and post-market monitoring. Compound Law advises MedTech companies and diagnostic AI developers on navigating the MDR–AI Act intersection, including dual-framework documentation strategies and notified body coordination. Our [AI medical diagnosis compliance guide](/en-DE/compliance/ai-medical-diagnosis/) details the specific obligations, and our [pharmaceutical AI Act page](/en-DE/ai-act/pharmaceuticals/) covers related GxP and clinical trial compliance situations." } }, { "@type": "Question", "name": "How do the EU AI Act and the EU MDR interact for AI-powered medical devices?", "acceptedAnswer": { "@type": "Answer", "text": "The EU AI Act and the EU Medical Device Regulation (MDR) create overlapping but distinct compliance obligations for AI-powered medical devices in Germany. Under EU AI Act Article 28, AI systems already subject to MDR conformity assessment by a notified body do not need a separate AI Act conformity assessment — but they must still satisfy the substantive AI Act requirements for high-risk systems (Articles 9–17), including technical documentation, quality management, and post-market monitoring. Both frameworks align on transparency, documentation, and human oversight, but diverge on definitions and specific procedural requirements. MedTech companies should conduct a dual-framework gap analysis to identify where existing MDR compliance already satisfies AI Act obligations and where additional steps are needed. Compound Law advises healthcare and MedTech companies in Germany and the DACH region on integrated MDR and EU AI Act compliance strategies." } } ] } ] ```